ED isn't just a bedroom problem — it's a vascular problem. The same disease process that causes erectile dysfunction is actively damaging your coronary arteries. Research shows ED precedes a heart attack or stroke by an average of 3–5 years. This is a window of opportunity — not a window to ignore.
Erectile dysfunction doesn't exist in isolation. It follows a predictable vascular progression — and understanding this timeline could save your life.
The penile arteries (1–2mm diameter) are among the smallest in the body. Endothelial dysfunction and early atherosclerosis restrict blood flow here first — often years before larger coronary arteries are affected.
Plaque buildup, chronic inflammation, and endothelial damage continue to progress in coronary and peripheral arteries — typically without any chest pain or obvious cardiac symptoms.
By the time a cardiovascular event occurs, the disease has been developing for years. ED was the body's earliest accessible warning — and in most cases, it was treated with a pill instead of a proper evaluation.
Erectile dysfunction and cardiovascular disease aren't just correlated — they're driven by the same underlying vascular mechanisms.
The endothelium (inner lining of blood vessels) regulates blood flow via nitric oxide. When damaged, it cannot dilate properly — causing both ED and reduced coronary blood flow.
Plaque buildup narrows arteries throughout the body. Smaller penile arteries show symptoms first, but the same process is occurring in coronary, carotid, and peripheral arteries.
Elevated hs-CRP, IL-6, and TNF-α damage blood vessel walls systemically. This inflammatory state drives both erectile dysfunction and cardiovascular disease progression.
Insulin resistance, visceral obesity, hypertension, and dyslipidemia create a cluster of risk factors that simultaneously impair sexual function and cardiovascular health.
The "artery size" hypothesis explains why ED appears before heart disease. The penile arteries are 1–2mm in diameter, while coronary arteries are 3–4mm. When atherosclerosis and endothelial dysfunction begin to narrow blood vessels, the smallest arteries are affected first.
A landmark study published in the Journal of the American College of Cardiology found that men with ED had a 2x increased risk of cardiovascular events compared to men without ED — independent of traditional risk factors like smoking, diabetes, and hypertension.
The Princeton III Consensus guidelines now recommend that all men presenting with ED should undergo cardiovascular risk assessment — because ED should be treated as a sentinel symptom of systemic vascular disease.
If you have ED alongside any of these risk factors, a comprehensive vascular assessment isn't optional — it's urgent.
We treat ED as the cardiovascular risk marker it is — with diagnostics that go far beyond a standard physical or a quick prescription.
Most men with ED receive a PDE5 inhibitor prescription (Viagra, Cialis) and no further investigation. While these medications improve erections, they do nothing to address the underlying vascular disease that caused the ED in the first place.
Prescribing a PDE5 inhibitor without investigating cardiovascular risk is like treating a smoke alarm by removing the batteries. The alarm isn't the problem — the fire is.
At ReGenesis, we use ED as the diagnostic opportunity it is: a chance to identify and treat vascular disease years before it causes a heart attack or stroke.
Comprehensive vascular and ED assessment at two Alberta locations.
Windermere Plaza
213, 5540 Windermere Blvd, Edmonton, AB T6W 2Z8
Silk Touch
1102, 8561 8A Ave SW, Calgary, AB T3H 0V5